Correction to: A case study of a bispecific antibody manufacturability assessment and optimization during discovery stage and its implications

DOI: https://doi.org/10.1093/abt/tbae021

2024-08-27

Abstract:[This corrects the article DOI: 10.1093/abt/tbae013.].

What problem does this paper attempt to address?

Correction to "Primary T-cell-based delivery platform for in vivo synthesis of engineered proteins"

DOI: https://doi.org/10.1002/btm2.10658

2024-03-10

Abstract:[This corrects the article DOI: 10.1002/btm2.10605.].
Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Hang-Ping Yao,Liang Feng,Sreedhar Reddy Suthe,Ling-Hui Chen,Tian-Hao Weng,Chen-Yu Hu,Eun Sung Jun,Zhi-Gang Wu,Wei-Lin Wang,Song Cheol Kim,Xiang-Min Tong,Ming-Hai Wang

DOI: https://doi.org/10.1186/s40425-019-0571-7

IF: 12.469

2019-01-01

Journal for ImmunoTherapy of Cancer

Abstract:Following publication of the original article [1], the author reported two errors in the authors affiliations:
Correction To: Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar Assessment

Dominique Gouty,Chun‐Hua Cai,Xiaoyan Cai,Aparna Kasinath,Vijay Kumar,S. Alvandkouhi,Jianhong Yang,Susan Pederson,Bruce Babbitt,David Peritt,Anita C. Rudy,Vera Koppenburg,Angelo M. Taveira DaSilva,Martin Ullmann,S. Liu,Christina Satterwhite

DOI: https://doi.org/10.1208/s12248-018-0189-6

2018-01-01

Abstract:In the published article, the author B. Babbitt was cited as affiliation 9, but should have been cited as affiliation 2. In addition, there are 2 errors in the affiliations. The correct affiliations are shown in this erratum.
Corrections to "An Optimized Safe Process from Bench to Pilot cGMP Production of API Eptifibatide Using a Multigram-Scale Microwave-Assisted Solid-Phase Peptide Synthesizer"

Annunziata D'Ercole,Lorenzo Pacini,Giuseppina Sabatino,Matteo Zini,Lorenzo Milli,Francesca Nuti,Arianna Ribecai,Alfredo Paio,Paolo Rovero,Anna Maria Papini

DOI: https://doi.org/10.1021/acs.oprd.2c00224

2022-08-19

Abstract:[This corrects the article DOI: 10.1021/acs.oprd.1c00368.].
Erratum: Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2023.1353758

2023-12-15

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1194610.].
Publisher Correction: Immunoglobulin Deposition on Biomolecule Corona Determines Complement Opsonization Efficiency of Preclinical and Clinical Nanoparticles

Vivian P. Vu,Geoffrey B. Gifford,Fangfang Chen,Halli Benasutti,Guankui Wang,Ernest V. Groman,Robert Scheinman,Laura Saba,Seyed Moein Moghimi,Dmitri Simberg

DOI: https://doi.org/10.1038/s41565-019-0379-0

IF: 38.3

2019-01-01

Nature Nanotechnology

Abstract:In the version of this Article originally published, a technical error led to Fig. 1a containing ‘!!!!!!!!’ above the scale bar. This has now been corrected in all versions of the Article.
Erratum: Elimination of large tumors in mice by mRNA-encoded bispecific antibodies

Christiane R Stadler,Hayat Bähr-Mahmud,Leyla Celik,Bernhard Hebich,Alexandra S Roth,René P Roth,Katalin Karikó,Özlem Türeci,Ugur Sahin

DOI: https://doi.org/10.1038/nm1017-1241d

IF: 82.9

2017-10-01

Nature Medicine

Abstract:Nat. Med. 23, 815–817 (2017); published online 12 June 2017; corrected after print 20 July 2017 In the version of this article initially published, in the “Polymer/lipid-based formulation of mRNA” section of the Online Methods, the text incorrectly stated that mRNA was in 190 ml rather than 190 ml of cold DMEM.

biochemistry & molecular biology,cell biology,medicine, research & experimental
Corrigendum to Antibody Response to BNT162b2 Vaccine in Immune Modifiers-Treated Psoriatic Patients

DOI: https://doi.org/10.1177/24755303231195874

Abstract:[This corrects the article DOI: 10.1177/24755303211056059.].
Correction: Minimising the payload solvent exposed hydrophobic surface area optimises the antibody–drug conjugate properties

Adrian D. Hobson,Haizhong Zhu,Wei Qiu,Russell A. Judge,Kenton Longenecker

DOI: https://doi.org/10.1039/d4md90009j

2024-01-01

RSC Medicinal Chemistry

Abstract:Correction for ‘Minimising the payload solvent exposed hydrophobic surface area optimises the antibody–drug conjugate properties’ by Adrian D. Hobson et al. , RSC Med. Chem. , 2024, https://doi.org/10.1039/d3md00540b.

biochemistry & molecular biology,chemistry, medicinal
Corrigendum to “Aptamer-Based Cell-Free Detection System to Detect Target Protein” [synth Syst Biotechnol 6 (3) (2021) 209–215]

Junhong Chen,Xiaoyan Zhuang,Jiyang Zheng,Ruofan Yang,Fei Wu,Aihui Zhang,Baishan Fang

DOI: https://doi.org/10.1016/j.synbio.2023.05.001

IF: 4.692

2023-01-01

Synthetic and Systems Biotechnology

Abstract:[This corrects the article DOI: 10.1016/j.synbio.2021.07.004.].
Correction to "Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance"

Geetika Dhanda,Yash Acharya,Jayanta Haldar

DOI: https://doi.org/10.1021/acsomega.4c05153

IF: 4.1

2024-06-18

ACS Omega

Abstract:[This corrects the article DOI: 10.1021/acsomega.3c00312.][This corrects the article DOI: 10.1021/acsomega.3c03063.].
Correction to “Micelle Maker: An Online Tool for Generating Equilibrated Micelles as Direct Input for Molecular Dynamics Simulations”

Dennis M Krüger,Shina C L Kamerlin,Dennis M. Krüger,Shina C. L. Kamerlin

DOI: https://doi.org/10.1021/acsomega.3c08868

IF: 4.1

2023-11-28

ACS Omega

Abstract:[This corrects the article DOI: 10.1021/acsomega.7b00820.].

chemistry, multidisciplinary
Correction: Corrigendum: the Changing Shape of Vaccination: Improving Immune Responses Through Geometrical Variations of a Microdevice for Immunization

Michael L. Crichton,David A. Muller,Alexandra C. I. Depelsenaire,Frances E. Pearson,Jonathan Wei,Jacob W. Coffey,Jin Zhang,Germain J. P. Fernando,M. A. F. Kendall

DOI: https://doi.org/10.1038/srep28722

IF: 4.6

2016-01-01

Scientific Reports

Abstract:Scientific Reports 6: Article number: 27217; published online: 02 June 2016; updated: 04 July 2016 The original version of this Article contained typographical errors in the spelling of the author Alexandra Christina Isabelle Depelsenaire which was incorrectly given as Alexandra Christina Isobel Depelsenaire.
Correction to "Mannosylated STING Agonist Drugamers for Dendritic Cell-Mediated Cancer Immunotherapy"

Dinh Chuong Nguyen,Kefan Song,Simbarashe Jokonya,Omeed Yazdani,Drew L Sellers,Yonghui Wang,Abm Zakaria,Suzie H Pun,Patrick S Stayton

DOI: https://doi.org/10.1021/acscentsci.4c00532

2024-04-16

Abstract:[This corrects the article DOI: 10.1021/acscentsci.3c01310.].
Erratum to “Responsive Inverse Opal Scaffolds with Biomimetic Enrichment Capability for Cell Culture”

Changmin Shao,Yuxiao Liu,Junjie Chi,Jie Wang,Ze Zhao,Yuanjin Zhao

DOI: https://doi.org/10.34133/2022/9850304

IF: 11

2022-02-04

Research

Abstract:[This corrects the article DOI: 10.34133/2019/9783793.].

multidisciplinary sciences
Erratum: Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer

DOI: https://doi.org/10.3233/BLC-219500

2021-03-19

Bladder Cancer

Abstract:[This corrects the article DOI: 10.3233/BLC-200013.].
Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]

Zhilin Li,Hao Cai,Zhiqian Li,Long Ren,Xuelei Ma,Hongyan Zhu,Qiyong Gong,Hu Zhang,Zhongwei Gu,Kui Luo

DOI: https://doi.org/10.1016/j.bioactmat.2022.09.016

IF: 18.9

2023-04-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.028.].

engineering, biomedical,materials science, biomaterials
Correction to: Biomarkers in clinical epidemiology studies

DOI: https://doi.org/10.1093/ckj/sfae293

2024-09-28

Abstract:[This corrects the article DOI: 10.1093/ckj/sfae130.].
Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles"

Kin Man Au,Rod Balhorn,Monique C Balhorn,Steven I Park,Andrew Z Wang

DOI: https://doi.org/10.1021/acscentsci.4c00703

2024-05-08

Abstract:[This corrects the article DOI: 10.1021/acscentsci.8b00746.].
Erratum: Publisher's Note: "A suspended layer additive manufacturing approach to the bioprinting of tri-layered skin equivalents" [APL Bioeng. 5, 046103 (2021)]

Richard J A Moakes,Jessica J Senior,Thomas E Robinson,Miruna Chipara,Aleksandar Atanasov,Amy Naylor,Anthony D Metcalfe,Alan M Smith,Liam M Grover

DOI: https://doi.org/10.1063/5.0151285

2023-04-03

Abstract:[This corrects the article DOI: 10.1063/5.0061361.].

Correction to: A case study of a bispecific antibody manufacturability assessment and optimization during discovery stage and its implications

Correction to "Primary T-cell-based delivery platform for in vivo synthesis of engineered proteins"

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Correction To: Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar Assessment

Corrections to "An Optimized Safe Process from Bench to Pilot cGMP Production of API Eptifibatide Using a Multigram-Scale Microwave-Assisted Solid-Phase Peptide Synthesizer"

Erratum: Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity

Publisher Correction: Immunoglobulin Deposition on Biomolecule Corona Determines Complement Opsonization Efficiency of Preclinical and Clinical Nanoparticles

Erratum: Elimination of large tumors in mice by mRNA-encoded bispecific antibodies

Corrigendum to Antibody Response to BNT162b2 Vaccine in Immune Modifiers-Treated Psoriatic Patients

Correction: Minimising the payload solvent exposed hydrophobic surface area optimises the antibody–drug conjugate properties

Corrigendum to “Aptamer-Based Cell-Free Detection System to Detect Target Protein” [synth Syst Biotechnol 6 (3) (2021) 209–215]

Correction to "Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance"

Correction to “Micelle Maker: An Online Tool for Generating Equilibrated Micelles as Direct Input for Molecular Dynamics Simulations”

Correction: Corrigendum: the Changing Shape of Vaccination: Improving Immune Responses Through Geometrical Variations of a Microdevice for Immunization

Correction to "Mannosylated STING Agonist Drugamers for Dendritic Cell-Mediated Cancer Immunotherapy"

Erratum to “Responsive Inverse Opal Scaffolds with Biomimetic Enrichment Capability for Cell Culture”

Erratum: Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer

Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]

Correction to: Biomarkers in clinical epidemiology studies

Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles"

Erratum: Publisher's Note: "A suspended layer additive manufacturing approach to the bioprinting of tri-layered skin equivalents" [APL Bioeng. 5, 046103 (2021)]